In 2020, the COVID-19 pandemic exacerbated barriers to care and treatment for individuals experiencing opioid use disorder. Experts estimate a record-setting 90,000 people died of a drug overdose in ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...
Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior ...
ASTHO interview with Elizabeth Harvey, PhD, MPH, a CDC Senior Maternal and Child Health Epidemiology Program assignee to the Tennessee Department of Health. Harvey shares her thoughts on the progress ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
This brief outlines key considerations for state health departments to address the increase in overdose-related deaths during the postpartum period.
In 2023 legislative sessions, states considered measures to improve access to care for pregnant people experiencing substance use disorder, increase provider knowledge of screening and treatment ...
Support from postpartum doulas can can increase parental self-efficacy and adherence to treatment for those experiencing SUD, leading to lower rates of postpartum depression and, subsequently, ...
Infographic depicting findings on a survey around opioid use among pregnant people.
Polysubstance Use During Pregnancy and the Benefits of Universal Verbal Screening polysubstance use, universal verbal screening, health equity, polysubstance use during pregnancy, public health, ...
This training is designed to be used with the ASTHO Opioid Use Disorder Toolkit: Supporting the Public Health Response in Maternal, Child and Adolescent Health to “role play” or practice what you ...